Main Navigation

Quick Links

Startup news: The latest out of Myriad Genetics, Sarcos and Techcyte

Categories:

University of Utah startups continue innovating and discovering solutions to today’s unmet needs. Here’s a roundup of some of the latest news out of these companies: New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced results from a nationwide […]

Read More

Academia in Action: Applying industry lessons to academia

Categories:

For some, the pathway to a faculty position at a university can be long and circuitous, but that doesn’t stop these faculty members from applying the lessons from their unique backgrounds to their academic research. Many University of Utah professors found their way to the U after working in industry. Check out some of their […]

Read More

Academia in Action: From academia to industry and back again

Categories:

The pathway to a faculty position at a university can be long and circuitous. For Abigail Pulsipher, a research assistant professor in the Otolaryngology and Molecular Pharmaceutics departments, that journey took her from a postdoc in California to working at a University of Utah spinout company—GlycoMira—before landing her current position at the U. Pulsipher has […]

Read More

Startup news: The latest out of J3 Bioscience, Lineage Cell Therapeutics, Myriad Genetics and SymbioCellTech

Categories:

University of Utah startups continue innovating and discovering solutions to today’s unmet needs. Here’s a roundup of some of the latest news out of these companies: Park City Angels announces additional investment in J3 Bioscience The Park City Angels are pleased to announce that our members have made an additional investment in J3 Bioscience. J3 Bioscience is […]

Read More

Startup news: The latest out of Summit Venture Studio

Categories:

University of Utah startups continue innovating and discovering solutions to today’s unmet needs. Here’s a roundup of some of the latest news out of these companies: Summit Venture Studio Licenses Graduly Through Brigham Young University Graduly, a financial planning tool, has announced its licensing agreement with Summit Venture Studio through Brigham Young University. Graduly was […]

Read More

Academia in Action: Searching for rare disease treatments

Categories:

By their very nature, rare diseases impact a smaller portion of the population compared to conditions like cancer or the flu. While these diseases are less common, those affected by them, along with University of Utah researchers, are actively searching for a cure. Treating patients as individuals: Clement Chow “The current state of rare disease […]

Read More

Startup news: The latest out of Myriad Genetics and SymbioCellTech

Categories:

University of Utah startups continue innovating and discovering solutions to today’s unmet needs. Here’s a roundup of some of the latest news out of these companies: Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Onsite Women’s […]

Read More

Academia in Action: Translating fundamental science for impact

Categories:

Every university researcher has their first introduction to technology transfer at some point in their career. Many scientists might have a knee jerk, negative reaction to the idea of commercialization, but University of Utah biochemistry assistant professor Minna Roh-Johnson said she recently realized pursuing basic science and translating research out of the lab is not […]

Read More

Startup news: The latest out of Inherent Biosciences and Myriad Genetics

Categories:

University of Utah startups continue innovating and discovering solutions to today’s unmet needs. Here’s a roundup of some of the latest news out of these companies: Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH Inherent Biosciences, Inc., a commercial-stage life science company, is at the forefront of innovation with its […]

Read More